A5017557317- Immunodeficiency and Autoimmune Disorders
- Nuclear Structure and Function
- Blood disorders and treatments
- IgG4-Related and Inflammatory Diseases
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Radiation Dose and Imaging
- Tracheal and airway disorders
- Antiplatelet Therapy and Cardiovascular Diseases
- Esophageal and GI Pathology
- Autoimmune and Inflammatory Disorders
- Pituitary Gland Disorders and Treatments
- Cardiac Imaging and Diagnostics
- Soft tissue tumor case studies
- Neuroendocrine Tumor Research Advances
- Health Systems, Economic Evaluations, Quality of Life
- Radiopharmaceutical Chemistry and Applications
- Dysphagia Assessment and Management
- Meningioma and schwannoma management
- Growth Hormone and Insulin-like Growth Factors
Universidade de Santiago de Compostela
2019-2023
Complejo Hospitalario de Ourense
2022-2023
Universidade da Coruña
2021
Complejo Hospitalario Universitario de Santiago
2019-2020
Complexo Hospitalario Universitario A Coruña
2020
Abstract Background Lipodystrophy syndromes are a group of disorders characterized by loss adipose tissue once other situations nutritional deprivation or exacerbated catabolism have been ruled out. With the exception HIV-associated lipodystrophy, they very low prevalence, which together with their large phenotypic heterogeneity makes identification difficult, even for endocrinologists and pediatricians. This leads to significant delays in diagnosis misdiagnosis. Our has developed an...
Abstract Background: Lipodystrophy syndromes are a group of disorders characterized by loss adipose tissue once other situations nutritional deprivation or exacerbated catabolism have been ruled out. With the exception HIV-associated lipodystrophy, they very low prevalence, which together with their large phenotypic heterogeneity makes identification difficult, even for endocrinologists and pediatricians. This leads to significant delays in diagnosis misdiagnosis. Our has developed an...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Abstract Lipodystrophy syndromes are a group of disorders characterized by loss adipose tissue once other situations nutritional deprivation or exacerbated catabolism have been ruled out. With the exception HIV-associated lipodystrophy, they very low prevalence, which together with their large phenotypic heterogeneity makes identification difficult, even for endocrinologists and pediatricians. This leads to significant delays in diagnosis misdiagnosis. Objective: Our has developed an...
Abstract Background: Lipodystrophy syndromes are a group of disorders characterized by loss adipose tissue once other situations nutritional deprivation or exacerbated catabolism have been ruled out. With the exception HIV-associated lipodystrophy, they very low prevalence, which together with their large phenotypic heterogeneity makes identification difficult, even for endocrinologists and pediatricians. This leads to significant delays in diagnosis misdiagnosis. Our has developed an...